Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
T. Wang (Chengdu, China), Y. Lan (Chengdu, China), H. Wang (Chengdu, China), N. Zeng (Chengdu, China), F. Wen (Chengdu, China). Angiopoietin like 4 as a clinical biomarker for acute respiratory distress syndrome. 2180

Member's Comments

No comment yet.

Related content which might interest you: Wnt5a and Wnt11 as acute respiratory distress syndrome biomarkers for severe acute respiratory syndrome coronavirus 2 patients Source: Eur Respir J, 56 (5) 2001531; 10.1183/13993003.01531-2020 Year: 2020 Neuregulin-1 as a potentially novel biomarker in acute respiratory distress syndrome Source: Eur Respir J 2013; 41: 259-261 Year: 2013 Epidemiology and prognosis of acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=1 Year: 2002 Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management Year: 2006 Pathogenesis of acute microvascular lung injury and the acute respiratory distress syndrome Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=22 Year: 2002 The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance Source: Eur Respir J 2014; 43: 276-285 Year: 2004 Clinico-pathological analysis of acute respiratory distress syndrome (ARDS) Source: Annual Congress 2012 - Multidisciplinary critical care Year: 2012 An animal model of the acute respiratory distress syndrome (ARDS) Source: Eur Respir J 2002; 20: Suppl. 38, 486s Year: 2002 Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome Source: Eur Respir Rev, 29 (156) 200114; 10.1183/16000617.0114-2020 Year: 2020 Corticosteroids and acute respiratory distress syndrome (ARDS) Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 COVID-19 patient with acute respiratory distress syndrome (ARDS) benefit most from an early prone position Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Early intervention with non-invasive respiratory therapies in mild acute respiratory distress syndrome secondary to COVID-19 Source: Virtual Congress 2021 – Non-invasive respiratory support in COVID-19 Year: 2021 Severe acute respiratory distress syndrome due to ipilimumab Source: Eur Respir J 2013; 42: 866-868 Year: 2013 Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome Source: Eur Respir J 2003; 21: 720-727 Year: 2003 Proteinomics and ARDS Source: Annual Congress 2007 - Acute respiratory distress syndrome: from basic science to bedside Year: 2007 Corticosteroids in acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 The impact of two partial ventilatory support modalities on lung histology and inflammatory mediators in a model of acute respiratory distress syndrome Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007 Phenotypes of acute respiratory distress syndrome Source: Virtual Congress 2021 – Respiratory critical care Year: 2021 KL-6 levels are elevated in plasma from patients with acute respiratory distress syndrome Source: Eur Respir J 2004; 23: 142-145 Year: 2004